CitroTech Inc. Annual Report: A Plain-English Guide

I’ve put together this guide to help you understand how CitroTech performed this year. My goal is to cut through the corporate jargon so you can decide if this company belongs in your portfolio.

The latest data shows CitroTech is in a "heavy lifting" phase. They rely on outside funding and complex financial deals to keep the lights on.

1. What does the company do?

CitroTech develops technology for processing citrus, specifically automated extraction and preservation systems. They are currently moving from research and development into commercial sales. They manage $14.2 million in debt through convertible notes and pay $2.8 million in fees to companies controlled by their own board members.

2. Financial performance

The company is prioritizing survival over profit. They reported a $9.4 million loss on only $3.1 million in revenue. A large chunk of their $6.2 million in operating costs goes toward paying board-affiliated companies for advisory and accounting services. Their business is fragile: two clients provide 68% of their revenue, and one manufacturer supplies 75% of their critical hardware.

3. Major wins and challenges

• The Challenge: The company holds $18.7 million in short-term debt. In 2025, they raised cash by issuing $5 million in new debt and $2 million in preferred stock. These deals include options for lenders to buy 4.5 million shares at $0.45 each. This will likely push the stock price down in the future.
• The Activity: The company is aggressively restructuring. They turned $3.5 million of old debt into 7.8 million shares and issued another 1.2 million shares to pay consultants. While this saves cash, it constantly issues new shares, which reduces the value of your existing holdings.

4. Financial health

CitroTech is not yet self-sustaining and burns through $650,000 every month. Because they cannot get traditional bank loans, they accept high-cost financing. For every $1.00 they borrow, they owe $1.25 back, indicating that the company struggles to find affordable capital.

5. Key risks

The biggest risk is dilution. The total number of shares increased by 22% this year, meaning your "slice of the pie" is shrinking as the company prints new shares to pay debts and insiders. Additionally, the company paid $450,000 in consulting fees to the CEO’s spouse—a figure 15% higher than the industry average.

6. Future outlook

CitroTech is still building, having spent $6 million on patents and equipment this year. They hope to turn a profit by the end of 2026. However, they must keep raising money just to survive the next 12 months. Until they make money from their products rather than selling stock or debt, this remains a highly speculative investment.

---

Final Thought for Investors: When looking at a company like this, ask yourself if you are comfortable with the high level of dilution and the reliance on board-affiliated service providers. If the company cannot reach profitability by 2026, they will likely need to continue issuing more shares, which will further impact the value of your investment.

Disclaimer: I am an AI, not a financial advisor. This guide is for informational purposes only and does not constitute financial advice.